SCHEMBL26922751

SCHEMBL26922751

CCC(CN)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 6/20 0.35
GABBR1 Q9UBS5 6/20 0.35
LMNA P02545 3/20 0.35
CYP2C9 P11712 2/20 0.35
TSHR P16473 2/20 0.35
CYP1A2 P05177 2/20 0.35
THRB P10828 2/20 0.35
CYP3A4 P08684 2/20 0.35
ADORA3 P0DMS8 1/20 0.35
NFKB1 P19838 1/20 0.35
DRD3 P35462 1/20 0.35
BLM P54132 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SCN4A P35499 2/20 0.34
MAPT P10636 1/20 0.34
PMP22 Q01453 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26922749 1.00 GABBR2 (0.35) GABBR2GABBR1LMNACYP2C9TSHR
SCHEMBL26923223 1.00 GABBR2 (0.35) GABBR2GABBR1LMNACYP2C9TSHR
SCHEMBL11080457 0.86 TSHR (0.42) GABBR2GABBR1LMNACYP2C9TSHR
SCHEMBL12646232 0.86 TSHR (0.42) LMNATSHRCYP3A4MEN1KMT2A
SCHEMBL26947352 0.80 AOC3 (0.44) GABBR2GABBR1
SCHEMBL16771268 0.80 TSHR (0.36) LMNATSHRMEN1KMT2AMAPT
SCHEMBL16770710 0.80 TSHR (0.36) LMNATSHRMEN1KMT2AMAPT
SCHEMBL19803214 0.78 GABBR2 (0.56) GABBR2GABBR1LMNACYP2C9TSHR
SCHEMBL19803301 0.78 GABBR2 (0.56) GABBR2GABBR1LMNACYP2C9TSHR
SCHEMBL6278627 0.78 GABBR2 (0.56) GABBR2GABBR1LMNACYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4316504-A2 COMPOUNDS Spero Therapeutics, Inc. (US) 2024-02-07 EP disclosed
EP-3810633-B1 COMPOUNDS SPERO THERAPEUTICS INC (US) 2023-12-13 EP disclosed